HCID 178477695、化合物 → HCID 178477694、化合物

HRID 1888222ノート

反応式

HRID 1888222 の反応式
[CH2:1]([S:3]([N:6]1[CH2:11][CH2:10][CH:9]([C:12]2[C:20]3[C:15](=[C:16]([C:29]([NH2:31])=[O:30])[CH:17]=[C:18]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([CH2:27][OH:28])[CH:22]=4)[CH:19]=3)[NH:14][N:13]=2)[CH2:8][CH2:7]1)(=[O:5])=[O:4])[CH3:2]>C1COCC1.O=[Mn]=O>[CH2:1]([S:3]([N:6]1[CH2:7][CH2:8][CH:9]([C:12]2[C:20]3[C:15](=[C:16]([C:29]([NH2:31])=[O:30])[CH:17]=[C:18]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([CH:27]=[O:28])[CH:22]=4)[CH:19]=3)[NH:14][N:13]=2)[CH2:10][CH2:11]1)(=[O:4])=[O:5])[CH3:2]

参加物

4

実験手順

To a solution of 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[3-(hydroxymethyl)phenyl]-1H-indazole-7-carboxamide (Intermediate 23) (130 mg, 0.294 mmol) in THF (50 mL) was added MnO2 (900 mg, 8.8 mmol). The reaction mixture was stirred at room temperature overnight and filtered. The filtrate was concentrated at reduced pressure to give the crude title compound, which was used in the next step without further purification.

後処理

  1. filtrationfiltered
  2. concentrationThe filtrate was concentrated at reduced pressure

出典と根拠

ORDレコード
ord-bf1020875a604530a53e9e5b08318098
出典データセット
uspto-grants-2013_08
特許番号
US08501780B2

反応ノート

読み込み中…